Theravance Biopharma
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
相关临床试验
17
15 进行中
药物批准
2
批准总数
监管机构
1
监管机构数
成立时间
1996
进行中（未招募）
15
88.2%
已完成
2
11.8%
暂无资讯文章
